NOVOSEVEN 2 MG (100K UI) INJ FL + FL
(Facteur de coagulation VIIa recombinant EPTACOG ALFA [activé]) - Maladie rare sans désignation orpheline
Treatment of bleeding episodes and for the prevention of bleeding in those undergoing surgery or invasive procedures in the following patient groups :
- patients with congenital haemophilia with inhibitors to coagulation factors VIII or IX > 5 BU
- patients with congenital haemophilia who are expected to have a high anamnestic response to factor VIII or factor IX administration
- patients with acquired haemophilia
- patients with congenital FVII deficiency
- patients with Glanzmann’s thrombasthenia with antibodies to GP IIb - IIIa and/or HLA, and with past or present refractoriness to platelet transfusions.